High glucose decreases collagenase expression and increases TIMP expression in cultured human peritoneal mesothelial cells

Nephrology Dialysis Transplantation

Volumn 23, Issue 2, 2008, Pages 534-541

  Kim, Jin Ju ^a   Li, Jin Ji ^a,b   Kim, Kyung Sik ^a   Kwak, Seung Jae ^a   Jung, Dong Sub ^a   Ryu, Dong Ryeol ^c   Yoo, Tae Hyun ^a   Choi, Hoon Young ^a   Han, Seung Hyeok ^a   Kim, Hyung Jong ^a   Yoon, Soo Young ^d   Han, Dae Suk ^a   Kang, Shin Wook ^a  

^a Yonsei University College of Medicine   (South Korea)

^b YANBIAN UNIVERSITY MEDICAL COLLEGE   (China)

^c Ewha Womans University School of Medicine   (South Korea)

^d Kwandong University College of Medicine   (South Korea)

Author keywords

Collagenases; High glucose; Mesothelial cells; Peritoneal fibrosis; TIMPs

Indexed keywords

COLLAGENASE; COLLAGENASE 3; GLUCOSE; INTERSTITIAL COLLAGENASE; MANNITOL; NEUTROPHIL COLLAGENASE; PROTEIN KINASE INHIBITOR; TISSUE INHIBITOR OF METALLOPROTEINASE;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; MESOTHELIUM CELL; PERITONEUM CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION;

CELLS, CULTURED; COLLAGENASES; EPITHELIAL CELLS; FIBRILLAR COLLAGENS; FIBROSIS; GLUCOSE; HUMANS; PERITONEUM; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 44449164953     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfm553     Document Type: Article

References (20)

1. Plum J, Hermann S, Fussholler A et al. Peritoneal sclerosis in peritoneal dialysis patients related to dialysis settings and peritoneal transport properties. Kidney Int 2001; 59 [Suppl 78]: S42-S47
2. Dobbie JW. Pathogenesis of peritoneal fibrosing syndromes (sclerosing peritonitis) in peritoneal dialysis. Perit Dial Int 1992; 12: 14-27
3. Adler S. Structure-function relationships associated with extracellular matrix alterations in diabetic glomerulopathy. J Am Soc Nephrol 1994; 5: 1165-1172
4. Ayo SH, Radnik RA, Glass WF II et al. Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 1991; 260: F185-F191
5. Kitamura M, Kitamura A, Mitarai T et al. Gene expression of metalloproteinase and its inhibitor in mesangial cells exposed to high glucose. Biochem Biophys Res Commun 1992; 185: 1048-1054
6. Stylianou E, Jenner LA, Davies M, Coles GA, Williams JD. Isolation, culture and characterization of human peritoneal mesothelial cells. Kidney Int 1990; 37: 1563-1570
7. Ha H, Yu MR, Lee HB. High glucose-induced PKC activation mediates TGF-b1 and fibronectin synthesis by peritoneal mesothelial cells. Kidney Int 2001; 59: 463-470
8. Xu ZG, Kim KS, Park HC et al. High glucose activates the p38 MAPK pathway in cultured human peritoneal mesothelial cells. Kidney Int 2003; 63: 958-968
9. Martin J, Yung S, Robson RL, Steadman R, Davies M. Production and regulation of matrix metalloproteinases and their inhibitors by human peritoneal mesothelial cells. Perit Dial Int 2000; 20: 524-533
10. Higuchi C, Tanihata Y, Nishimura H, Naito T, Sanaka T. Effects of glucose and plasminogen activator inhibitor-1 on collagen metabolism in the peritoneum. Ther Apher Dial 2005; 9: 173-181
11. Del Prete D, Anglani F, Forino M et al. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia 1997; 40: 1449-1454
12. McLennan SV, Kelly DJ, Cox AJ et al. Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 2002; 45: 268-275
13. Hirahara I, Ogawa Y, Kusano E, Asano Y. Activation of matrix metalloproteinase-2 causes peritoneal injury during peritoneal dialysis in rats. Nephrol Dial Transplant 2004; 19: 1732-1741
14. Hirahara I, Inoue M, Okuda K, Ando Y, Muto S, Kusano E. The potential of matrix metalloproteinase-2 as a marker of peritoneal injury, increased solute transport, or progression to encapsulating peritoneal sclerosis during peritoneal dialysis - a multicentre study in Japan. Nephrol Dial Transplant 2007; 22: 560-567
15. Fukudome K, Fujimoto S, Sato Y, Hisanaga S, Eto T. Peritonitis increases MMP-9 activity in peritoneal effluent from CAPD patients. Nephron 2001; 87: 35-41
16. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92: 827-839
17. Renvall S, Lehto M, Penttinen R. Development of peritoneal fibrosis occurs under the mesothelial cell layer. J Surg Res 1987; 43: 407-412
18. Ma C, Tarnuzzer RW, Chegini N. Expression of matrix metalloproteinases and tissue inhibitor of matrix metalloproteinases in mesothelial cells and their regulation by transforming growth factor-b1. Wound Repair Regen 1999; 7: 477-485
19. McLennan SV, Fisher E, Martell SY et al. Effects of glucose on matrix metalloproteinase and plasmin activities in mesangial cells: possible role in diabetic nephropathy. Kidney Int 2000; 58 [Suppl 77]: S81-S87
20. Ayo SH, Radnik R, Garoni JA, Troyer DA, Kreisberg JI: High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 1991; 261: F571-F577